Humaira Shoaib, MD

Call
Website

Advertisement

76 Th Ave
New Hyde Park, NY 11040

Humaira Shoaib, MD, is a medical practice nestled in New Hyde Park, NY, offering a range of healthcare services to its patients. With a focus on providing comprehensive medical care, they cater to diverse needs through primary care, hospital treatments, urgent care facilities, advanced surgical procedures, and diagnostic services. The dedicated professionals at Humaira Shoaib, MD, are actively involved in medical research, educational initiatives, and community health programs to enhance patient care and healthcare outcomes in the local area.

At Humaira Shoaib, MD, a commitment to excellence is evident through their dedication to staying at the forefront of healthcare advancements. Through continuous engagement in innovative technologies, clinical trials, and collaborative partnerships, they strive to promote wellness and improve the overall health of the communities they serve. Patients can trust Humaira Shoaib, MD, to deliver quality healthcare services while fostering a culture of compassion, innovation, and continuous improvement in the medical field.

Generated using this brand's available information

Own this business?
See a problem?

You might also like

Margarita Kats, MD

I am a pediatric hematologist/oncologist who specializes in stem cell transplantation and cellular therapy. I graduated from the Upstate Medical University, completed a residency in pediatrics at the Schneider Children's Hospital, served as Chief Resident of Pediatrics at the Schneider Children's Hospital, and then completed my training with a fellowship in pediatric hematology / oncology at the Children s Hospital of Philadelphia. During my fellowship, I concurrently spent 3 years in the laboratory researching cellular immunotherapy for acute lymphoblastic leukemia, while also pursuing a clinical interest in the late effects of childhood cancer treatment. In 2008 I came to the Cohen Children s Medical Center to found Survivors Facing Forward, a long-term follow-up program to provide care to survivors of childhood cancer and stem cell transplantation. Since 2008, the program has grown to follow nearly 1,000 survivors of childhood cancer and has been a fertile source for clinical research. In 2021 I assumed leadership of the stem cell transplantation and cellular therapy program at Cohen Children's Medical Center, where I am the Transplant Center Medial Director and Marrow Collection Facility Director. Our transplant center participates in national and international cooperative group studies in the use of stem cell transplantation and cellular therapy to treat cancers, bone marrow failure syndromes, immune deficiencies and hemoglobinopathies (sickle cell disease and thalassemia). Notably, we are one of a very limited number of Qualified Treatment Centers (QTC) for Zynteglo , an FDA approved gene therapy for transfusion dependent thalassemia, and are in the process of being named a QTC for gene therapy products recently FDA approved to cure sickle cell disease.
Psychiatrists and psychoanalysts

Mary V. Solanto, PHD

Clinical and Research InterestsDr. Solanto's clinical and research interests are centered on the diagnosis and treatment of ADHD across the lifespan, including: Cognitive and behavioral functioning of children with ADHD Clinical effects and mechanisms of action of stimulant medications Characteristics of the subtypes of ADHD in children and adults Cognitive-Behavioral treatment of ADHD in Adults Cognitive-Behavioral treatment of ADHD in College StudentsAwards Dr. Solanto has been the recipient of multiple NIH grants including a grant from NIMH to support development of a cognitive-behavioral intervention to treat adult ADHD American Journal of Psychiatry (2010). This CBT intervention was recognized as Innovative Program of the Year by CHADD (2011). Dr. Solanto received a Fulbright US Scholar Award to teach and conduct research on ADHD in college students in the Netherlands (2017-2018) BooksSolanto, M.V., Arnsten, A., Castellanos, F.X. (Eds.) (2001). Stimulant Drugs and AD/HD: Basic and Clinical Neuroscience. New York: Oxford University Press. Solanto, M. V. (2011). Cognitive-Behavioral Therapy for Adult ADHD: Targeting Executive Dysfunction. New York, N.Y.: Guilford Press.Selected Recent PublicationsSolanto, M.V. (2019). The Prevalence of "Late-Onset" ADHD in a Clinically Referred Adult Sample. Journal of Attention Disorders, 23 (9):1026-1034. Solanto, M.V. & Surman, C. (2018). Response of Older Adults to Cognitive Behavioral-Therapy for ADHD. ADHD Attention Deficit and Hyperactivity Disorders (Official Journal of the World Federation of ADHD). 10 (3):223-235.Leikauf, J. & Solanto, M.V. (2016). Sluggish Cognitive Tempo, Internalizing Symptoms, and Executive Function in Adults with ADHD. Journal of Attention Disorders, 21 (8), 701-711.Adler, LA., Solanto, M.V., Escobar, R., Lipsius, S., & Upadhyaya, H. (2016). Executive Functioning Outcomes Over 1 Year of Atomoxetine for Adults with ADHD and Relationship to Maintenance of Response and Relapse. Epub ahead of print, 2016 Aug 13, Journal of Attention Disorders.Membership on Professional Advisory BoardsChildren and Adults with ADHD (CHADD)National Center for Learning Disabilities (NCLD) American Professional Society for Research in ADHD and Related Disorders (APSARD)
United StatesNew YorkNew Hyde ParkHumaira Shoaib, MD

Advertisement